These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22672335)

  • 1. Shedding-generated Met receptor fragments can be routed to either the proteasomal or the lysosomal degradation pathway.
    Ancot F; Leroy C; Muharram G; Lefebvre J; Vicogne J; Lemiere A; Kherrouche Z; Foveau B; Pourtier A; Melnyk O; Giordano S; Chotteau-Lelievre A; Tulasne D
    Traffic; 2012 Sep; 13(9):1261-72. PubMed ID: 22672335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis.
    Foveau B; Ancot F; Leroy C; Petrelli A; Reiss K; Vingtdeux V; Giordano S; Fafeur V; Tulasne D
    Mol Biol Cell; 2009 May; 20(9):2495-507. PubMed ID: 19297528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Met degradation: more than one stone to shoot a receptor down.
    Lefebvre J; Ancot F; Leroy C; Muharram G; Lemière A; Tulasne D
    FASEB J; 2012 Apr; 26(4):1387-99. PubMed ID: 22223753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase cleavage of the MET receptor generates an HGF interfering fragment.
    Deheuninck J; Foveau B; Goormachtigh G; Leroy C; Ji Z; Tulasne D; Fafeur V
    Biochem Biophys Res Commun; 2008 Mar; 367(3):573-7. PubMed ID: 18187039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-associated epithelial cell adhesion molecule is slowly cleaved by γ-secretase prior to efficient proteasomal degradation of its intracellular domain.
    Huang Y; Chanou A; Kranz G; Pan M; Kohlbauer V; Ettinger A; Gires O
    J Biol Chem; 2019 Mar; 294(9):3051-3064. PubMed ID: 30598504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis.
    McElroy B; Powell JC; McCarthy JV
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1136-41. PubMed ID: 17524361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of the GAB1 adaptor by the ubiquitin-proteasome pathway hampers HGF/SF-MET signaling.
    Goormachtigh G; Ji Z; Le Goff A; Fafeur V
    Biochem Biophys Res Commun; 2011 Aug; 411(4):780-5. PubMed ID: 21782801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B; Xia S; Abounader R; Laterra J
    Clin Cancer Res; 2005 Jun; 11(12):4479-86. PubMed ID: 15958633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding.
    Park KC; Geleta B; Leck LYW; Paluncic J; Chiang S; Jansson PJ; Kovacevic Z; Richardson DR
    J Biol Chem; 2020 Jan; 295(2):481-503. PubMed ID: 31744884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-proteasome pathway mediates degradation of APH-1.
    He G; Qing H; Cai F; Kwok C; Xu H; Yu G; Bernstein A; Song W
    J Neurochem; 2006 Dec; 99(5):1403-12. PubMed ID: 17059559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrosis- and apoptosis-related Met cleavages have divergent functional consequences.
    Montagne R; Berbon M; Doublet L; Debreuck N; Baranzelli A; Drobecq H; Leroy C; Delhem N; Porte H; Copin MC; Dansin E; Furlan A; Tulasne D
    Cell Death Dis; 2015 May; 6(5):e1769. PubMed ID: 25996296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
    Accornero P; Martignani E; Macchi E; Baratta M
    J Dairy Sci; 2007 Sep; 90(9):4289-96. PubMed ID: 17699048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas.
    Hecht M; Papoutsi M; Tran HD; Wilting J; Schweigerer L
    Cancer Res; 2004 Sep; 64(17):6109-18. PubMed ID: 15342394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the c-Met receptor complex in fibroblasts drives invasive cell behavior by signaling through transcription factor STAT3.
    Cramer A; Kleiner S; Westermann M; Meissner A; Lange A; Friedrich K
    J Cell Biochem; 2005 Jul; 95(4):805-16. PubMed ID: 15838885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist.
    Kirchhofer D; Lipari MT; Santell L; Billeci KL; Maun HR; Sandoval WN; Moran P; Ridgway J; Eigenbrot C; Lazarus RA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5306-11. PubMed ID: 17372204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.